Tremelimumab, CAS [[745013-59-6]]

Produktübersicht

• Artikelname: Tremelimumab, CAS [[745013-59-6]]
• Artikelnummer: TGM-T77466
• Hersteller Artikelnummer: T77466
• Alternativnummer: TGM-T77466-1MG,TGM-T77466-5MG,TGM-T77466-10MG,TGM-T77466-25MG,TGM-T77466-50MG,TGM-T77466-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: Ticilimumab , CP-675206

Produktbeschreibung

Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and lung cancer.

Produkteigenschaften

• Reinheit: 98.70%
• CAS Nummer: [745013-59-6]
• Target-Kategorie: Others|||Immunology/Inflammation related

Bilder

T77466